This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The webinar and recording are available below to everyone thanks to our sponsor, Revvity Signals, and the slides are available for download to Premium members at the bottom. Presentation Slides for Members: Upgrade Membership to Download Slide Deck The post Recent Highlights in Targeted Protein Degradation appeared first on Drug Hunter.
In Wednesday’s Flash Talk webinar, we covered recent highlights in covalent drug discovery, with lots of great questions from the audience. The webinar and recording are available below to everyone thanks to our sponsor, Revvity Signals, and the slides are available for download to Premium members at the bottom.
On March 18, 2025, Drug Channels Institute will release The 2025 Economic Report on U.S. drug pricing, reimbursement, and dispensing system. prescription drug channels. prescription drug channels. Those who preorder will receive a download link before March 18. Pharmacies and Pharmacy Benefit Managers.
Assessing the PEDAL platform as a means to identify drug-and-tumor pairings. Learn more about our Proof of Concept Study for the PEDAL platform from Predictive Oncology that features a unique combination of AI technology, drug response data and a biobank of over 150,000 tumor samples for 137 tumor types. Get started today.
Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCIs new live video webinar: PBM Industry Update: Trends, Challenges, and What's Ahead This event will be broadcast live on Friday, April 4, 2025, from 12:00 p.m. to 1:30 p.m. WHAT YOU WILL LEARN Join industry expert Adam J.
This lets you focus on what matters most: driving meaningful results in drug research and development. From advancing drug discovery, managing clinical trials, or developing new healthcare solutions, reliable and flexible access to quality data is essential for success.
As the pharmaceutical industry continues to evolve, drug developers encounter new challenges and opportunities in their pursuit of innovation. In response, the PPD clinical research business of Thermo Fisher Scientific conducted its third global survey of 150 drug developers to capture a comprehensive view of these evolving trends.
As regular readers of Drug Channels know, U.S. distribution and dispensing channels for prescription drugs are undergoing significant evolution and consolidation as the changing economics of pharmaceuticals challenge conventional business models. drug wholesaling industry. All rights reserved.
Some CRISPR screens may be missing cancer drug targets By Allessandra DiCorato June 14, 2024 Breadcrumb Home Some CRISPR screens may be missing cancer drug targets Current CRISPR guides don’t work equally well in cells from people of all ancestries, which could lead to false negative results.
To learn more about Phil’s access and commercialization solutions, download their free whitepaper, Modernize the Patient Access Experience: Transform Your Pharmaceutical Brand. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. You can also visit [link].
Fein, CEO of Drug Channels Institute (DCI), for three live video webinars during 2022. These live, interactive events will be broadcast via Zoom from the Drug Channels Video studio in beautiful downtown Philadelphia. Click here to order the Drug Channels 2022 Video Webinar Series. drug channel. drug channel.
How large volume subcutaneous delivery unlocks value and drives sales growth Learn how subcutaneous delivery helps drug developers stand out, improve patient experience, and drive growth. Download now to see how on-body devices simplify the switch. Download now to see how on-body devices simplify the switch.
Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new live video webinar: Drug Channels Outlook 2023. The webinar will be broadcast from the Drug Channels studio in beautiful downtown Philadelphia. d/b/a Drug Channels Institute. to 1:30 p.m.
Pharmacies and Pharmacy Benefit Managers , available for purchase and immediate download. Click here to download a free report overview (including key industry trends, the Table of Contents, and a List of Exhibits) New Drug Channels Institute Study Analyzes Impact of Inflation Reduction Act on U.S. d/b/a Drug Channels Institute.
Download now. Healthcasts Media Clinical Data Marketing Food and Drug Administration (FDA) Resource Type Whitepaper Healthcasts Logo Mon, 04/07/2025 - 10:57 Clinical Data Clinical Data Marketing Landing Page Url [link] Byline Sponsored by: Healthcasts
Pharmacies and Pharmacy Benefit Managers , available for purchase and immediate download. Click here to download a free report overview (including key industry trends, the Table of Contents, and a List of Exhibits) New Drug Channels Institute Study Examines Consolidation and Vertical Integration of U.S. WHAT’S GOING ON.
Pharmacies and Pharmacy Benefit Managers , available for purchase and immediate download. Download a free report overview (including key industry trends, the Table of Contents, and a List of Exhibits) HMP Global’s Drug Channels Institute releases ‘2024 Economic Report on U.S. drug pricing, reimbursement, and dispensing system.
Amongst other tasks, gget opentargets can quickly find diseases and drugs associated with a specific gene. For example, to find drugs associated with the human IL13 gene (Ensembl ID ENSG00000169194*), a cytokine that plays an important role in allergic inflammation and immune response to parasite infection, you can use: # Install gget !
Discover how to ensure drugs meet the highest standards before they reach the market. Discover how to ensure drugs meet the highest standards before they reach the market. Discover how to ensure drugs meet the highest standards before they reach the market.
On October 11, 2022, Drug Channels Institute will release The 2022–23 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. Those who preorder will receive a download link before October 11. CLICK HERE to download a free pre-publication draft overview. d/b/a Drug Channels Institute.
On March 14, 2023, Drug Channels Institute will release The 2023 Economic Report on U.S. drug pricing, reimbursement, and dispensing system. Those who preorder will receive a download link before March 14. we highlight potential implications of the IRA for the drug channel. d/b/a Drug Channels Institute.
Please download and share the free safety materials from NSC including a poster, social media kit, animated graphics, 5-minute safety talks, games, articles and more – plus NSC members get additional exclusive resources.
Our annual look at the state of the drug development industry highlights a dual set of challenges complicating progress. Rising costs have become a persistent challenge for drug developers, driven by a combination of internal and external pressures that have intensified in recent years.
On March 19, 2024, Drug Channels Institute will release The 2024 Economic Report on U.S. drug pricing, reimbursement, and dispensing system. prescription drug channels. prescription drug channels. Those who preorder will receive a download link before March 19. Pharmacies and Pharmacy Benefit Managers.
Nasir discusses how hubs help patients initiate and adhere to drug therapies. Based on CareMetx research, he outlines the key factors that drug manufacturers value in their hub partners. Learn more by downloading CareMetx’s full report: The Evolving Landscape of Digital Healthcare Hubs. d/b/a Drug Channels Institute.
To learn more, download CareMetx’s free 2022 Report - Patient Services Trends. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. Matt shares three key findings from CareMetx’s exclusive new survey on patient support services for specialty pharmaceuticals.
To learn more, download the Wolters Kluwer free ebook: Drug Data Unity: Realistic and Idealistic Futures for Information Exchange. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. She then discusses the practical issues behind implementing and adopting such a system.
To learn more, download AssistRx’s free eBook: Specialty Drug Patient Support Programs: 2022 Progress Report. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. He also describes the circumstances where each solution provides the greatest value.
On October 5, 2021, Drug Channels Institute will release The 2021–22 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. Those who preorder will receive a download link before October 5. CLICK HERE to download a free pre-publication draft overview. d/b/a Drug Channels Institute. to 1:30 p.m.
To learn more, download CoverMyMeds’ 2022 Medication Access Report. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. He describes patient-centric, data-driven solutions to help patients access, afford, and adhere to their therapies. Read on for John’s insights.
To learn more, download the Wolters Kluwer Expert Insight article Vertical Integration Strategies: Using Data to Align Partners and Reduce Variation in Care. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. Read on for Garry’s insights.
To learn more about CoverMyMeds’ comprehensive affordability solutions, download Overcoming Medication Affordability Challenges with Patient-Centered Solutions. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. Read on for Kristina’s insights.
To learn about AssistRx’s digital intake technologies, download their case study: Digital Intake for More Meaningful Patient and HCP Interactions. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. He outlines four key features of solutions that improve digital intake.
As regular readers know, the biosimilar boom for provider-administered drugs has been accelerating. That’s when Humira, the best-selling drug in the U.S., The video is excerpted from last month’s Specialty Drugs Update: Trends, Controversies, and Outlook video webinar. d/b/a Drug Channels Institute.
To learn more about the impact of hub service on brand launch success, download CareMetx’s latest report: Patient Service Trends Point the Way to Better Hub/ Provider Partnerships. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. Read on for Greg’s insights.
Next week, Drug Channels Institute will release our 2022 Economic Report on U.S. It’s the 13th edition of our popular and comprehensive examination of the entire drug pricing, reimbursement, and dispensing system. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.
As the clinical trial landscape evolves, drug developers are faced with novel challenges and changes in study recruitment, trial size and structure, and more. Decentralized Trials Digital and decentralized clinical trials (DCTs) continue to expand and have become a standard solution for drug developers.
Learn more about GoodRx’s insights and solutions for specialty treatments by downloading their free yellow paper: Access and Affordability Insights: Differences Across Specialties. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. Read on for Divya’s insights.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content